Business Context and Reporting Period
Company: IRADIMED CORP (IRMD)
Filing Type: Form 8-K (Current Report)
Report Date: July 30, 2021
Reporting Period: Second Quarter ended June 30, 2021
This filing serves as a notification that the company issued a press release announcing its financial results for the second quarter of 2021. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data points. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these metrics.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release but does not include the text of the commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 30, 2021) for actual Q2 2021 financial results.
- Verify specific revenue and net income figures against prior year and quarter comparisons in the press release.
- Check for any updated forward-looking guidance or management commentary in the press release.
- Confirm the company's status as an emerging growth company (indicated as checked in the filing).